reimbursement for travel expenses in connection with the above mentioned activities. JBB owns no stock. TF received speaker and advisory fees from Eli Lilly and Company and Novo Nordisk. WH-HS received speaker fees from Novo Nordisk, Eli Lilly and Company, Merck, Sharp & Dohme, Takeda, Boehringer Ingelheim, Bristol-Myers Squibb, AstraZeneca, Bayer, and Novartis, and advisory fees from Novo Nordisk, and Merck, Sharp & Dohme. SKS, CRH, BJH, and MKB are employees of Eli Lilly and Company or one of its subsidiaries, and are shareholders of Eli Lilly and Company. AG is an employee of PharmaNet/i3, which undertakes services for Eli Lilly and Company. MF is a former employee and shareholder of Amylin Pharmaceuticals LLC. LP is an employee and shareholder of Amylin Pharmaceuticals LLC